Back to companies

Aspen Pharmacare Holdings Ltd: Overview

Aspen Pharmacare Holdings Ltd (Aspen) is a provider of specialty and generic pharmaceuticals for the treatment of a range of acute and chronic conditions. The company focuses on thrombosis, anaesthetics and high potency and cytotoxic therapeutic categories. Its manufacturing capabilities cover a range of product types including oral solid dose, semi-solids, liquids, sterile, biological, personal care products and active pharmaceutical ingredients (APIs). The company has a presence in Sub-Saharan Africa, South East Asia, Latin America, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.

Gain a 360-degree view of Aspen Pharmacare Holdings Ltd and make more informed decisions for your business Gain a 360-degree view of Aspen Pharmacare Holdings Ltd and make more informed decisions for your business Find out more
Headquarters South Africa

Address Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive ,La Lucia Ridge, Durban


Telephone 27 31 5808600

No of Employees 8,580

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange APN (JNB)

Revenue (2023) $2.5B 2.2% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 35% (2023 vs 2022)

Market Cap* $4.1B

Net Profit Margin (2023) XYZ -23.6% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Aspen Pharmacare Holdings Ltd premium industry data and analytics

560+

Marketed Drugs

Understand Aspen Pharmacare Holdings Ltd’s commercialized product portfolio to stay one step ahead of the market.

40+

Clinical Trials

Determine Aspen Pharmacare Holdings Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

4

Catalyst Calendar

Proactively evaluate Aspen Pharmacare Holdings Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Aspen Pharmacare Holdings Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Aspen Pharmacare Holdings Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Anti-Depressants Diprivan
Anaesthetic Emla
Analgesics (for Pain Relief) Fraxiparine
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Aspen Pharmacare Holdings Ltd portfolio and identify potential areas for collaboration Understand Aspen Pharmacare Holdings Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In September, the company and Aspen SA Operations concluded an agreement with Novo Nordisk for the technical transfer and commercial manufacture of Human Insulins.
2023 Contracts/Agreements In August, the company entered into a distribution and promotion agreement with Eli Lilly Export S.A. to sell, promote and distribute Lilly’s pharmaceutical portfolio in South Africa and the rest of Sub-Saharan Africa.
2023 Contracts/Agreements In March, Aspen Healthcare FZ entered into a memorandum of understanding with Saudi Chemical Company Holding and its subsidiary AJA Pharmaceutical Industries to expand their existing partnership to strategically collaborate on an extended portfolio of products.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Aspen Pharmacare Holdings Ltd Pfizer Inc Merck & Co Inc Novartis AG AstraZeneca Plc
Headquarters South Africa United States of America United States of America Switzerland United Kingdom
City Durban New York Kenilworth Basel Cambridge
State/Province - New York New Jersey - England
No. of Employees 8,580 83,000 69,000 103,000 83,500
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Stephen Saad Director; Chief Executive Officer Executive Board 1999 58
Sean Capazorio Chief Financial Officer; Director Executive Board 2022 57
Lorraine Hill Group Operating Officer Senior Management - 59
Kuseni Dlamini Chairman Non Executive Board 2012 54
Samer Kassem Chief Executive Officer Senior Management 2008 47
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into Aspen Pharmacare Holdings Ltd key executives to enhance your sales strategy Gain insight into Aspen Pharmacare Holdings Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward